Big Bang Theory, page-7

Thank you Storm, I have learned a lot, but it's taken 1000's of hours.

I would like to add ACW's ability to enter commercial agreements with pharmaceutical giants is now in a much stronger position that we are in a phase II study and soon FDA approved and recruited and to add to that fully funded for the phase II to end of 2017.

We could see a massive pharmaceutical licensing agreements in place well before any phase II results for Alzheimer’s or other indications.

It was only 2 weeks ago the UK company, Heptares, that licensed with US giant Allergan shot up US$800m in market cap on the back of licensing its phase I Alzheimer’s drug.

ACW has the opportunity to become the giant in the ASX biotech space over the next 6 months to a year.